Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

That's partially true but until this week I was also a MNTA shareholder and frankly I was stunned to read Dew's latest valuation projections. I think it is so far from reality that it makes no sense to me(but then again he has always been wildly optimistic so maybe it should). And yet excepting myself and io nary a contrary word is spoken here. You may not like his delivery but surely many here can see that io makes some valid points. Every bit as valid as Dew's to be sure. These are all just opinions folks, and it is always beneficial to hear both sides.

In my view, the latest patent setback is a huge blow. An appeal notwithstanding, it means MNTA's lead over MYLAN has likely been wiped out. In 2015 there could easily be 2 generics, plus branded generic. Not to mention a completely new set of potential competitors to steal market share. How much does that leave for MNTA's take? Very possibly not enough to be profitable.

I am frankly shocked that the market hasn't punished MNTA further, but I fully expect that it will in short order. The only thing that may be propping it up thus far is the belief that they will win on appeal. On this I do not feel confident enough on to continue to hold. Even if they were able to win on appeal, how long with that take, a year? Longer? Why hold until that day more closely approaches?

I feel strongly that there are many here who read posts like these and agree strongly with the sentiment but are afraid to post about it because they know it will not be well received here.

And that is a damn shame.